Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
We evaluated the effect of Saccharomyces boulardii CNCM I-745 on intestinal neuromuscular anomalies in an IBS-type mouse model of gastrointestinal motor dysfunctions elicited by Herpes Simplex Virus type 1 (HSV-1) exposure.Mice were inoculated intranasally with HSV-1 (102 PFU) or vehicle at time 0 a...
Main Authors: | Paola Brun, Melania Scarpa, Chiara Marchiori, Gloria Sarasin, Valentina Caputi, Andrea Porzionato, Maria Cecilia Giron, Giorgio Palù, Ignazio Castagliuolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5521842?pdf=render |
Similar Items
-
Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
by: Paola Brun, et al.
Published: (2017-01-01) -
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
by: Stier H, et al.
Published: (2016-09-01) -
Protective effect of Saccharomyces boulardii CNCM I-745 on the development of inflammatory osteoclasts and inflammatory bone destruction
by: Maria-Bernadette Madel, et al.
Published: (2020-10-01) -
Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
by: Terciolo C, et al.
Published: (2019-02-01) -
The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
by: Rodolphe Pontier-Bres, et al.
Published: (2015-10-01)